FET fusion proteins reshape splicing factor networks to drive oncogenic alternative splicing
Gene fusions involving the FET gene family (FUS, EWSR1, and TAF15) act as drivers of numerous cancer entities. The resulting chimeric proteins are widely viewed as aberrant transcriptional regulators that promote malignant transformation through chromatin and enhancer reprogramming. Here, we show that FET fusion oncopr...